MedTrace Logo

Lupus Flares and Histological Renal Activity at the End of the Treatment (LuFla)

NCT02313974 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2016-09-14

No results posted yet for this study

Summary

At this moment, the duration of the treatment in Proliferative Lupus Nephritis has not been determined.

Almost 30 percent of patients in total remission during or after a treatment, will relapse in the first 5 years.

The factors associated to Renal relapses are not completly known. The investigators think that an histological control study performed to patient with complete remission for a year at the end of a 3 years treatment could help us to know which patients are going to relapse.

Conditions

Interventions

PROCEDURE

Renal Biopsy

Sponsors & Collaborators

  • Hospital de Clinicas José de San Martín

    lead OTHER

Principal Investigators

  • Marcelo A De Rosa, Physician · Hospital de Clinicas. UBA

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-11-30
Completion
2018-11-30

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02313974 on ClinicalTrials.gov